Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pipeline
Biotech
Recursion streamlines pipeline following merger with Exscientia
Evidently in the mood for spring cleaning, Recursion is clearing out part of its pipeline as it narrows its focus on oncology and rare diseases.
Fraiser Kansteiner
May 5, 2025 11:00am
AstraZeneca culls neuroscience meds in Q1 clear-out
Apr 29, 2025 7:08am
Caribou cuts 32% of staff, further purges cell therapy pipeline
Apr 24, 2025 9:55pm
Evotec axes 30% of assets as cost-cutting push hits pipeline
Apr 17, 2025 9:45am
Cyclacel sheds clinical asset in effort to stop cash spiral
Apr 2, 2025 6:01pm
ImmuneOnco axes CD47 bispecific amid pipeline prioritization
Mar 26, 2025 6:21am